Asian Tech Press (Mar. 17) -- India has been administering the homegrown Corbevax COVID-19 vaccine to people aged 12-14 years since Wednesday.

Manufactured by Hyderabad-based Biological E Ltd., Corbevax is India's first indigenously developed RBD-based subunit vaccine.

In February this year, Corbevax received emergency use authorisation (EUA) from India's drug regulator for the 12-18 years age group.